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Background: Pulmonary embolism (PE) is the most common preventable cause of hospital deaths, and almost all 
hospitalised patients have at least one risk factor for venous thromboembolism (VTE). Despite the availability of highly 
effective thromboprophylaxis in preventing VTE, numerous studies worldwide have demonstrated its under-utilisation. The aim 
of this study was to review and improve the utilisation of thromboprophylaxis in the prevention of VTE in hospitalised patients at 
Oudtshoorn district hospital, and to make recommendations to the Western Cape Department of Health on how to improve the 
quality of care for patients at risk for VTE at district hospitals.
Method: A quality improvement cycle (QIC). Retrospective analysis of files of adult patients admitted to the male and female 
wards at Oudtshoorn district hospital was performed prior to and after a five-month intervention phase. The target standards for 
the QIC were: (1) availability of a written hospital policy on VTE prevention; (2) every adult admission should have a formal VTE 
risk assessment documented; (3) every adult admission who is at risk for VTE should receive thromboprophylaxis.
Results: Some 38% of adult patients admitted to Oudtshoorn Hospital, excluding the maternity ward, were at risk of 
developing VTE. There was no written hospital policy on VTE prevention. This was developed and made available during the 
intervention. In the pre-intervention group there were no patients who had a documented VTE risk assessment. The post 
intervention group showed a considerable increase with 45.2% having had a completed VTE risk assessment on admission (p < 0.001). 
In the pre-intervention group only 4.6% of patients who were at risk of VTE received thromboprophylaxis. There was a statistically 
significant difference in the number of patients at risk who received thromboprophylaxis in the post-intervention group where 36% of 
these patients received thromboprophylaxis (p < 0.001).
Conclusions: The study identified a major shortcoming in the prevention of VTE in those patients at risk who were admitted 
to Oudtshoorn district hospital. An intervention as part of a quality improvement cycle has been able to demonstrate a 
significant improvement in the detection of patients who are at risk of VTE and a subsequent improvement in appropriate 
thromboprophylaxis. A number of barriers to their implementation have been identified and need to be addressed. This QIC may 
in time be of value to assist other district hospitals in addressing the issue of VTE prevention.
Keywords: district hospital, quality improvement, venous thromboembolism prevention
Background
Pulmonary embolism (PE) is the most common preventable 
cause of hospital deaths and is estimated to be the cause of 
approximately 10% of all deaths in hospitalised patients.1,2 In the 
United Kingdom a recent parliamentary report noted up to 
25 000 deaths per year from venous thromboembolism (VTE) 
associated with hospitalisation.3
Despite these alarming statistics, various international studies have 
demonstrated the under-utilisation of thromboprophylaxis for 
those patients who are at risk of developing VTE.4 This is not limited 
to the developing world as studies in Canada found that less than 
25% of at-risk hospitalised patients received thromboprohylaxis.4 A 
multitude of randomised control trials over many years have 
demonstrated that thromboprophylaxis is highly effective in 
preventing VTE and PE.1 Almost all hospitalised patients have at 
least one risk factor for VTE and about 40% have three or more risk 
factors.1 A multinational cross-sectional study of hospitalised 
patients showed that on average 52% (range 35% to 73%) were at 
risk of VTE.5 Therefore, a significant proportion of in-patients are at 
high risk of VTE and are not being protected against it.
In the United States, hospital-related PE has been ranked as the 
single most important intervention to improve patient safety in 
hospitals.6 The morbidity and mortality of VTE is significant. A 
single deep vein thrombosis (DVT) is associated with a vastly 
increased risk of recurrent events and long-term complications, 
which include post-thrombotic syndrome and pulmonary 
hypertension.7 These patients require long-term anticoagulation 
with its associated risks and costs. The annual costs involved with 
a single VTE event in the US have been estimated to be between 
$ 7 594 and $ 16 644.7
A number of international studies have attempted to bridge the 
gap between the established effectiveness of thromboprophylaxis 
and its clinical implementation. These studies have revolved 
around two main concepts. The first concept focused on which risk 
assessment models were accurate and user-friendly. These various 
models attempt to classify the degree of risk of VTE and are 
usually divided into medical and surgical models. The Southern 
African Society of Thrombosis and Haemostasis published the 
“Venous thromboembolism: Prophylactic and therapeutic practice 
guideline” in 2009, with a recent update in April 2013.2,8 It contains 
a user-friendly table of VTE risk subcategories, which is combined 
for surgical and non-surgical patients.2,8 This guideline provides a 
practical tool for risk assessment as well as recommendations on 
the means of thromboprophylaxis, but not measures to improve 
the rate of VTE prevention.
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Second, studies have looked to identify strategies to increase the 
use of thromboprophylaxis in at-risk patients. They all support 
active initiatives as opposed to passive (e.g. distribution of 
guidelines alone) with the most successful strategies being 
multifaceted and multidisciplinary. The interventions include a 
formal hospital policy with organisational change, various doctor 
reminders and decision support systems, staff education 
programmes, and regular audit processes.
There are currently no data on the incidence of VTE in South 
Africa. The aim of this study was to review and improve the 
utilisation of thromboprophylaxis in the prevention of VTE in 
hospitalised patients at Oudtshoorn district hospital, where this 
problem has been noted. The objectives were to assess the 
current quality of thromboprophylaxis; to plan and implement 
quality improvement measures; to determine if these were 
associated with a significant improvement in the quality of care; 
and to make recommendations to the Western Cape Department 
of Health on how to improve the quality of care for patients at 
risk for VTE at district hospitals.
Methods
Study design
The quality improvement cycle (QIC)  involves a cycle consisting 
broadly of setting target standards; monitoring current 
performance and comparing it with the target; effecting change 
and assessing its effectiveness to improve the quality of care 
(see Figure 1).
Setting
Oudtshoorn provincial hospital is a district hospital with 123 beds 
in the Eden district of the Western Cape, South Africa, serving a 
population of approximately 60 000 people. It has four wards 
(adult male, adult female, maternity, paediatric), an emergency 
centre, outpatient department and an anti-retroviral treatment 
clinic. The medical staff consists of three community service 
doctors and seven medical officers. There is an average of 50 
admissions per week to the general adult wards.
In addition to general medical admissions, the hospital 
performs various elective level 1 surgical procedures, including 
tonsillectomies, circumcisions and caesarean sections. 
Emergency surgeries performed include laparotomies for ectopic 
pregnancies and appendicectomies. Visiting specialist disciplines 
include internal medicine, family medicine, obstetrics and 
gynaecology, surgery, orthopaedics, ENT and ophthalmology.
Sampling and data collection
Data were collected by the author at the beginning of 2012 from 
250 patient files. The sample consisted of consecutive admissions 
to the adult wards split evenly between the male and female 
wards. This was done retrospectively by checking the admission 
entries in the ward admission registers and was intended to 
prevent bias, which might have occurred if the clinical team had 
been aware of an audit taking place. The sample size was 
determined with the help of the Department of Statistics at 
Stellenbosch University. Patient files were examined for the 
following variables:
(1)  Was a formal risk assessment done during admission?
(2)  What sub-category of VTE risk (low, moderate, high) was the 
patient?
(3)  Was thromboprophylaxis provided if at risk?
Patients were assigned to sub-categories of VTE risk depending 
on a number of variables obtained from their files. These included 
age, indication for admission, comorbidities, current medications 
and duration of surgery, among others. These variables were used 
in conjunction with the “Venous thromboembolism: prophylactic 
and therapeutic practice guideline” of the Southern African 
Society of Thrombosis and Haemostasis to assess the risk 
category of the patient.2
From these data the actual performance of the hospital in relation 
to each of the pre-determined criteria was analysed, and 
captured in an Excel spreadsheet.
Setting target standards
Almost all research and guidelines on this topic originate from 
a developed world setting. The American College of Chest 
Physicians (ACCP) recommends that every hospital develop a 
written policy and an active strategy to prevent VTE.1 In the 
United States the National Quality Forum and the Joint 
Commission both recommend that a formal risk assessment 
evaluation for VTE should be done on each patient on admission 
and regularly thereafter. Locally, the guidelines of the Southern 
African Society of Thrombosis and Haemostasis provide “clinical” 
standards focused on the desired outcomes of care, but not 
structural or process standards to improve the rate of appropriate 
thromboprophylaxis prescription.2 The target standards used for 
this QIC were as follows:
Structural 
A written hospital policy on VTE preventions. This included the 
various strategies needed to provide quality thromboprophylaxis.
Process
Every adult admission should have had a formal VTE risk 
assessment documented.
Outcome
Every adult admitted who was at risk for VTE should have received 
appropriate thromboprophylaxis. This may have taken the form 
of pharmacological or non-pharmacological means.
Comparing actual performance with target standards
The analysed data were compared with the target standards set 
out above.
Planning changes to improve quality
The interventions included a formal hospital policy with 
organisational changes, various doctor reminders and decision 
support systems, staff education programmes, and regular audit 
processes. Various studies including a systematic review of Figure 1: Steps of a quality improvement cycle
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interventions to improve prophylaxis for VTE have found that a 
number of active strategies implemented together are most 
likely to be successful in achieving optimal outcomes.9
In a discussion that the author had with the hospital manager, 
medical manager, most of the hospital doctors, male and female 
ward nursing managers and senior pharmacist a number of 
interventions were agreed upon that would be implemented to 
improve the quality of thromboprophylaxis (see Figure 2).
Implementing change
This took place over a five-month period from July to November 
2012.
Provider education
This included regular interaction with doctors and nursing 
staff on the importance of VTE prevention, the use of the risk 
assessment tool provided and the correct utilisation of 
thromboprophylaxis options.
An initial interactive teaching session was held, which provided 
the results of the current performance and compared it with the 
target standards. During this session the risk assessment tool was 
introduced and its use explained with the use of various patient 
scenarios. Follow-up sessions were held with the doctors and 
nursing staff. These were intended to address concerns and 
uncertainties as well as to reinforce the clinical importance of the 
intervention.
Provider reminder and decision support
A stamp was adapted from a VTE intervention used by the 
Salisbury NHS Foundation Trust in Salisbury, United Kingdom to 
include the risk subcategories of the Southern African Society of 
Thrombosis and Haemostasis VTE guidelines (see Figure 3).10  
It was placed on the back of the prescription chart where doctors’ 
orders were written and served to remind doctors to assess patients’ 
risk on admission and to prescribe appropriate thromboprophylaxis 
if indicated. If heparin was contraindicated in patients at risk of VTE 
the reason needed to be specified on the stamp. The nursing staff 
were requested to check whether the stamp had been completed. 
If not, they were to notify the ward doctor.
The risk assessment tool of the Southern African Society of 
Thrombosis and Haemostasis was chosen for the intervention 
due to its ease of use and because it takes into account the local 
context with its high burden of human immunodeficiency virus 
(HIV) and tuberculosis (TB), which most international tools fail to 
include. The fact that HIV infection causes a hypercoaguable 
state is well documented, with the prevalence of VTE in the 
HIV-infected population estimated to be as high as 18%.11,12
The tool was made available in the form of posters, which were 
placed at each desk in the emergency centre and outpatients 
department as well as at the work-stations of the adult wards. 
They were placed in a manner so as to be easily visible during the 
admission process of patients. Laminated A4 cards were also 
placed at each of these sites and on the ward round trolleys of the 
male and female wards.
Audit and feedback
An audit was performed at five months post-intervention 
(see data collection post-intervention below). It is recommended 
that this is repeated six-monthly by the medical manager and/or 
family physician with feedback to the clinical staff.
Hospital policy on VTE prevention
Together with the hospital manager, a policy was 
drawn up entitled: Oudtshoorn Hospital Policy on Venous 
Thrombo-Embolism (VTE) Prevention. Its stated purpose 
was to establish an effective, sustainable approach to the 
prevention of VTE in adult patients admitted to Oudtshoorn 
Hospital.
Data collection post-intervention
A repeat retrospective analysis was conducted five months after 
the initiation of the intervention to determine whether the 
prevalence of correct thromboprophylaxis administration had 
Figure 2: Intervention strategies used in the study
Figure 3: Stamp placed on treatment charts. Adapted from the Salisbury NHS Foundation Trust VTE prevention strategy10
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post-intervention groups (p = 0.079). The pre-intervention group 
included 86 patients at risk (34.4%) and the post-intervention group 
included 84 patients (42.7%). The reasons for this small difference 
between the two groups were not clear from the data (see Figure 5).
In the pre-intervention group, 86 patients were at risk of VTE. Of 
these only four patients received thromboprophylaxis (4.6%). 
There was a statistically significant difference in the number 
of patients at risk who received thromboprophylaxis in the 
post-intervention group where 31 of the 85 patients (36%) at risk 
received thromboprophylaxis (p < 0.001) (see Figure 6).
Discussion
A large proportion of adult patients admitted to Oudtshoorn 
hospital were at significant risk of developing VTE. The average 
percentage in the pre- and post-intervention groups showed that 
38.5% of all adult admissions were at moderate to high risk. This 
equates to slightly more than one in three admissions. It is not 
known how many of these patients actually developed either a 
DVT or PE. It is very likely that other district hospitals in the 
Western Cape which have comparable patient demographics and 
burden of disease would have similar percentages of patients at 
risk of VTE.
International data suggest a higher VTE risk than we found with this 
study. This may be due to an under-estimation of the actual risk, as 
the calculation of risk was done retrospectively by reviewing 
patient files. Various risk factors could not be easily elicited such as 
the body mass index (BMI) of the patient and a past history of DVT, 
which is not routinely asked and recorded in patient notes. We 
assessed risk only on the basis of available data in the patient file. It 
may also be due to the use of different risk assessment guidelines. 
The ENDORSE multinational cross-sectional study of 358 hospitals 
in 32 countries found that on average 52% of adult patients were at 
risk of VTE (range 35–73%). This was based on the American 
College of Chest Physicians consensus guidelines.5 Utilising these 
same guidelines a cross-sectional survey of 12 hospitals in Senegal 
found that 57% of patients were at risk of VTE. Both of these studies 
included medical admissions above the age of 40 and surgical 
admissions above 18 years of age.13
Prior to this intervention there was no strategy to prevent VTE at 
Oudtshoorn Hospital. The use of thromboprophylaxis was 
haphazard and was often only the continuation of treatment in a 
patient referred back from specialist care at the local referral 
hospital. There were no structured means of identifying patients 
who were at risk. This is clear from the fact that no patients had a 
formal VTE risk assessment, and that only 4.6% of patients at risk 
of VTE received thromboprophylaxis.
The under-utilisation of thromboprophylaxis is a worldwide 
problem that is not limited to the developing world. Alarmingly, 
in the pre-intervention group of this study the rate of appropriate 
thromboprophylaxis use (4.6% of patients at risk of VTE) was well 
below that cited internationally, where 58.5% of surgical and 
39.5% of medical patients at risk received thromboprophylaxis.5 
Data from another sub-Saharan country showed that 33.8% of 
medical and 37.5% of surgical patients at risk of VTE received 
thromboprophylaxis.13
The quality improvement intervention in our study led to a 
statistically significant improvement in the number of risk 
assessments done (p < 0.001) and the percentage of patients at 
risk who received thromboprophylaxis (p < 0.001). This 
should be seen in light of the very poor performance before the 
intervention. It is, however, an indication that improvement is 
changed. An additional sample of 199 patient files was assessed 
retrospectively for the same variables, and included consecutive 
admissions to the male and female wards.
Results
The study participants consisted of 250 adults in the pre- and 199 
adults in the post-intervention groups. There were equal numbers 
of male and female patients in the pre-intervention group. The 
post-intervention group showed a 59% male to 41% female split.
In the pre-intervention group there were no patients who had a 
documented VTE risk assessment. The post-intervention group 
showed a considerable increase with 90 patients (45.2%) having 
had a completed VTE risk assessment stamp on the admission 
chart (p < 0.001) (see Figure 4).
Patients are deemed at risk of VTE if they fall into the moderate- or 
high-risk categories. There was no statistically significant difference 
in the number of patients at risk of VTE between the pre- and 
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possible, and this could form the basis of an ongoing quality 
improvement programme. The intervention was based on a 
number of strategies that have been employed in quality 
improvement programmes internationally. Active quality 
improvement strategies in various hospitals in the UK based on 
similar interventions showed improvements in the rates of 
appropriate thromboprophylaxis from 59% to 70% (p < 0.05) and 
from 25% to 77% (p < 0.05) respectively.14
This QIC has determined target standards that can be used for 
follow-up audits to monitor performance. This is important in 
maintaining a sustainable intervention that has been shown to be 
effective. There are a number of barriers that have been identified 
and which can be overcome.
Limitations of this study
For the majority of the study and for the full duration of the 
intervention the author was working at the local referral hospital. 
This made it difficult to provide a consistent drive to the 
intervention in terms of motivating and reminding the clinical 
team of the need to assess patients on admission for their VTE 
risk. The presence of such a person might have resulted in further 
improvements in outcomes. A dedicated person, most likely the 
medical manager or family physician, will be needed to carry this 
quality improvement programme forward to ensure future 
sustainable improvement.
There were a number of further logistical factors that limited the 
intervention. These included the presence of several locum 
doctors working at the hospital as well as visiting specialists. It 
was difficult for the author not being on site to involve these 
clinicians. As part of a continued intervention they need to be 
introduced to this aspect of clinical care at the hospital and 
familiarised with the local protocols. Unfortunately not all doctors 
who work at the hospital attended the educational meetings that 
formed part of the intervention.
As mentioned earlier, the retrospective analysis of patient files 
was a methodological weakness of this study. Prospective 
analysis, however, would have required patient consent with the 
potential for bias as patients being aware of the intervention 
would have placed pressure on clinicians to prescribe 
thromboprophylaxis, which may have skewed the results.15
Conclusion
In all, 38% of adult patients admitted to Oudtshoorn hospital 
(excluding the maternity ward) were at risk of developing VTE. 
This study identified a major shortcoming in the prevention of 
VTE in these patients. An intervention as part of a quality 
improvement cycle was able to demonstrate a significant 
improvement in the detection of patients who are at risk of VTE 
and a subsequent improvement in the administration of 
appropriate thromboprophylaxis. Much still needs to be done to 
bring the quality of VTE prevention to that of the study target 
standards. However, these targeted interventions have shown 
the potential to make a difference. A number of barriers to their 
implementation have been identified and will need to be 
addressed. This QIC may in time be of value in assisting other 
district hospitals to address the issue of VTE prevention.
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